Biotechnology · Immunology & Inflammation Therapeutics
Abivax | news and milestones
Abivax |: 10 headlines on record, 7 headlines in the last 90 days. Its story counts 6 milestones.
Data updated Nov 20, 2026 · Back to the company report
10Headlines
7In 90 days
6Milestones
Newsroom
Headlines
Sep 262026
News · YahooFinance
ABIVAX Société Anonyme (NASDAQ:ABVX) reported first-half 2026 operating cash use of €102.5 million on September 21, up from €66.6 million a year earlier. The roughly 54% increase…
Sep 232026
Press release · The Globe and Mail
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Sep 232026
News · Pulse 2.0
Abivax, a clinical-stage biotechnology company developing treatments for chronic inflammatory diseases, reported its first-half 2026 financial results and announced several leade…
Sep 222026
News · RTTNews
Abivax SA (ABVX, ABVX.PA), a clinical-stage biotechnology company, reported first-half 2026 financial results, reflecting a wider net loss, and provided an update on near-term mi…
Sep 222026
News · marketscreener.com
Sep 222026
News · markets.businessinsider.com
Abivax Presents Business Updates and First Half 2026 Financial Results Chris Rabbat to succeed Fabio Cataldi as Chief Medical Officer; Tim Kelly a...
Sources: the outlets named on each headline, each story once
Milestones
Dec 1, 2023
Mar 31, 2023
Sep 30, 2022
Aug 20, 2015
Jun 8, 2014
Dec 4, 2013
Founded per the company register
Each milestone is dated by its source: registers, filings, the press
How to cite
Abivax |, News. Alion, Nov 20, 2026. https://alion.io/company/abivax/news
